Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
申请人:Genentech, Inc.
公开号:US10988478B1
公开(公告)日:2021-04-27
Compounds of Formula 0, Formula I, and Formula II and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.
本文描述了式 0、式 I 和式 II 的化合物以及用作白细胞介素-1 受体相关激酶(IRAK4)抑制剂的方法。
PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
申请人:F. Hoffmann-La Roche AG
公开号:EP3394066A2
公开(公告)日:2018-10-31
[EN] PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS<br/>[FR] DÉRIVÉS PYRAZOLO [1,5 A]PYRIMIDINE EN TANT QUE MODULATEURS D'IRAK 4